Delivery Order SPE2DB25D3306-SPE2DB25FUBQA
- Not listed
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $38,472.49 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packages) under a firm fixed-price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-competitive delivery order against an existing contract vehicle. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract valued at $35,010.98. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed without set-aside designation. Performance of this pharmaceutical supply contract will be fulfilled from AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,964.90 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on July 17, 2025, with completion scheduled for July 18, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $9,653.81 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical supply vehicle valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sprycel 100 mg tablets (30-count) with a ceiling value of $11,013.24 under firm fixed price terms. This non-set-aside, competitively awarded contract is classified as a delivery order and has an ultimate completion date of September 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $13,143.67 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing under a delivery order contract type and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) with a ceiling value of $41,700.72. This firm fixed-price delivery order, awarded on August 28, 2025, represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. As a child contract, this delivery order...
- The Defense Logistics Agency awarded a $5,665.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive award carries no set-aside designation and is to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, fulfills this order as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (60-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB25FUBQADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,387.97 to AmerisourceBergen Drug Corp for Sprycel 100 mg tablets (30-count) on May 5, 2025, with completion expected by May 6, 2025. This firm fixed-price, competitively awarded delivery order represents a routine pharmaceutical supply transaction under the company's existing contract vehicle with DLA. The award carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania headquarters. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen supplies critical medications across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The award of this Sprycel delivery reflects the company's ongoing role as a primary vendor for specialized pharmaceutical products within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 5/5/25 |